SCHEMBL28996776

SCHEMBL28996776

C[C@@]1(n2ccc(=S)[nH]c2=O)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC28A1 O00337 1/20 0.39
SLC28A2 O43868 1/20 0.39
SLC29A1 Q99808 1/20 0.39
SLC28A3 Q9HAS3 1/20 0.39
P2RY14 Q15391 2/20 0.36
P2RY6 Q15077 3/20 0.36
P2RY2 P41231 2/20 0.36
P2RY4 P51582 2/20 0.36
PYGB P11216 5/20 0.36
PYGL P06737 3/20 0.36
PYGM P11217 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002015 0.88 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL12658269 0.88 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL42133 0.88 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
Hydrogen Sulfide SCHEMBL28043850 0.87 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
Ammonia Solution, Strong SCHEMBL28145131 0.87 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL31439434 0.84 P2RY6 (0.39) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
Phosphoric Acid SCHEMBL18486662 0.84 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
Phosphoric Acid SCHEMBL18486628 0.84 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL6028061 0.84 SLC28A1 (0.42) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL29186646 0.83 PYGM (0.48) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122060818-A Chemically modified circular RNA molecules, methods of making and uses thereof 上海元码智药生物技术有限公司 2026-05-19 CN disclosed
CN-119842712-A 3' UTR for improving mRNA translation efficiency and application thereof 北京臻知医学科技有限责任公司 2025-04-18 CN disclosed
CN-119013398-A Novel method for producing polynucleotides comprising oligonucleotides 葛兰素史密斯克莱知识产权发展有限公司 2024-11-22 CN disclosed
CN-112236438-B Phosphorus (V) based reagent, method for the production thereof, and use thereof for producing stereoregular organic phosphorus (V) compounds 百时美施贵宝公司 2024-10-15 CN disclosed
CN-114127285-B Methods and compositions for editing nucleotide sequences 布罗德研究所股份有限公司 2024-09-10 CN disclosed
CN-112996854-B High purity PEG lipids and uses thereof 摩登纳特斯有限公司 2024-08-30 CN disclosed
CN-118076631-A Modeling antibody responses to antigens using antibodies 瑞泽恩制药公司 2024-05-24 CN disclosed
CN-118043306-A Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2024-05-14 CN disclosed
CN-114391008-B Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2024-05-03 CN disclosed
CN-117440824-A RNA vaccine against SARS-CoV-2 variants 库瑞瓦格欧洲公司 2024-01-23 CN disclosed
CN-117222422-A Sanopassing polypeptides and their use in the treatment of cancer 旗舰创业创新五公司 2023-12-12 CN disclosed
CN-116814614-A UTR sequence 埃泽瑞斯公司 2023-09-29 CN disclosed
CN-116726203-A Combination of MRNA encoding immunomodulatory polypeptides and uses thereof 莫得纳特斯公司 2023-09-12 CN disclosed
CN-116685682-A Guided editing guide RNAs, compositions thereof, and methods of using the same 布罗德研究所股份有限公司 2023-09-01 CN disclosed
CN-109154001-B UTR sequence 埃泽瑞斯公司 2023-07-18 CN disclosed
CN-109476718-B Combination of MRNA encoding immunomodulatory polypeptides and uses thereof 莫得纳特斯公司 2023-07-04 CN disclosed
CN-116096873-A Methods and compositions for editing two strands of a target double-stranded nucleotide sequence simultaneously 布罗德研究所股份有限公司 2023-05-09 CN disclosed